Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 257543, 12 pages
http://dx.doi.org/10.1155/2014/257543
Research Article

Resveratrol Counteracts Inflammation in Human M1 and M2 Macrophages upon Challenge with 7-Oxo-Cholesterol: Potential Therapeutic Implications in Atherosclerosis

1Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
2Laboratory of Vascular Pathology, Istituto Dermopatico dell’Immacolata, IDI-IRCCS, 00167 Rome, Italy
3Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy
4Department of Physiology and Pharmacology “Vittorio Erspamer”, La Sapienza University of Rome, 00181 Rome, Italy
5Department of Medico-Surgical Sciences and Biotechnology, Sapienza University of Rome, 04100 Latin, Italy

Received 13 February 2014; Revised 8 April 2014; Accepted 8 April 2014; Published 8 May 2014

Academic Editor: Kota V. Ramana

Copyright © 2014 Brigitta Buttari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. K. Hansson and A. Hermansson, “The immune system in atherosclerosis,” Nature Immunology, vol. 12, no. 3, pp. 204–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Libby, P. M. Ridker, and G. K. Hansson, “Progress and challenges in translating the biology of atherosclerosis,” Nature, vol. 473, no. 7347, pp. 317–325, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Gui, A. Shimokado, Y. Sun, T. Akasaka, and Y. Muragaki, “Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery,” Mediators of Inflammation, vol. 2012, Article ID 693083, 14 pages, 2012. View at Publisher · View at Google Scholar
  4. J. Vaya, “The association between biomarkers in the blood and carotid plaque composition-focusing on oxidized lipids, oxysterols and plaque status,” Biochemical Pharmacology, vol. 86, pp. 15–18, 2013. View at Publisher · View at Google Scholar
  5. S. Tavakoli and R. Asmis, “Reactive oxygen species and thiol redox signaling in the macrophage biology of atherosclerosis,” Antioxidants & Redox Signaling, vol. 17, pp. 1785–1795, 2012. View at Google Scholar
  6. D. M. Mosser and J. P. Edwards, “Exploring the full spectrum of macrophage activation,” Nature Reviews Immunology, vol. 8, no. 12, pp. 958–969, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Gordon and F. O. Martinez, “Alternative activation of macrophages: Mechanism and functions,” Immunity, vol. 32, no. 5, pp. 593–604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Helming and S. Gordon, “Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules,” European Journal of Immunology, vol. 37, no. 1, pp. 33–42, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. F. O. Martinez, L. Helming, and S. Gordon, “Alternative activation of macrophages: an immunologic functional perspective,” Annual Review of Immunology, vol. 27, pp. 451–483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Locati, A. Mantovani, and A. Sica, “Macrophage activation and polarization as an adaptive component of innate immunity,” Advances in Immunology, vol. 120, pp. 163–184, 2013. View at Publisher · View at Google Scholar
  11. A. Berthier, S. Lemaire-Ewing, C. Prunet et al., “7-Ketocholesterol-induced apoptosis: involvement of several pro-apoptotic but also anti-apoptotic calcium-dependent transduction pathways,” The FEBS Journal, vol. 272, no. 12, pp. 3093–3104, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Deckert, L. Perségol, L. Viens et al., “Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins: cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation,” Circulation, vol. 95, no. 3, pp. 723–731, 1997. View at Google Scholar · View at Scopus
  13. W. Jessup, P. Wilson, K. Gaus, and L. Kritharides, “Oxidized lipoproteins and macrophages,” Vascular Pharmacology, vol. 38, no. 4, pp. 239–248, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Larsson, Y. Böttiger, L. Iuliano, and U. Diczfalusy, “In vivo interconversion of 7β-hydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress,” Free Radical Biology and Medicine, vol. 43, no. 5, pp. 695–701, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Buttari, L. Segoni, E. Profumo et al., “7-Oxo-cholesterol potentiates pro-inflammatory signaling in human M1 and M2 macrophages,” Biochemical Pharmacology, vol. 86, pp. 130–137, 2013. View at Publisher · View at Google Scholar
  16. J. O. Clarke and G. E. Mullin, “A review of complementary and alternative approaches to immunomodulation,” Nutrition in Clinical Practice, vol. 23, no. 1, pp. 49–62, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Catalgol, S. Batirel, Y. Taga, and N. K. Ozer, “Resveratrol: French paradox revisited,” Frontiers in Pharmacology, vol. 3, p. 141, 2012. View at Google Scholar
  18. B. Buttari, E. Profumo, A. Capozzi et al., “Advanced glycation end products of human β2 glycoprotein I modulate the maturation and function of DCs,” Blood, vol. 117, no. 23, pp. 6152–6161, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Buttari, E. Profumo, F. Facchiano et al., “Resveratrol prevents dendritic cell maturation in response to advanced glycation end products,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 574029, 12 pages, 2013. View at Publisher · View at Google Scholar
  20. J. Walker, K. Schueller, L. M. Schaefer, M. Pignitter, L. Esefelder, and V. Somoza, “Resveratrol and its metabolites inhibit pro-inflammatory effects of lipopolysaccharides in U-937 macrophages in plasma-representative concentrations,” Food & Function, vol. 5, pp. 74–84, 2014. View at Google Scholar
  21. M. Leidi, E. Gotti, L. Bologna et al., “M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than M1 cells in vitro,” Journal of Immunology, vol. 182, no. 7, pp. 4415–4422, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Pu, J. Yin, Y. Wu et al., “The association between CD14 gene C-260T polymorphism and coronary heart disease risk: a meta-analysis,” Molecular Biology Reports, vol. 40, pp. 4001–4008, 2013. View at Publisher · View at Google Scholar
  23. E. Galkina and K. Ley, “Immune and inflammatory mechanisms of atherosclerosis,” Annual Review of Immunology, vol. 27, pp. 165–197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. T. T. Huang, H. C. Lai, Y. B. Chen et al., “cis-Resveratrol produces anti-inflammatory effects by inhibiting canonical and non-canonical inflammasomes in macrophages,” Innate Immunity, 2013. View at Publisher · View at Google Scholar
  25. P. J. Murray and T. A. Wynn, “Protective and pathogenic functions of macrophage subsets,” Nature Reviews Immunology, vol. 11, no. 11, pp. 723–737, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Peiser and S. Gordon, “The function of scavenger receptors expressed by macrophages and their rolein the regulation of inflammation,” Microbes and Infection/Institut Pasteur, vol. 3, no. 2, pp. 149–159, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Porta, M. Rimoldi, G. Raes et al., “Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 35, pp. 14978–14983, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Suffee, H. Hlawaty, A. Meddahi-Pelle et al., “RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans,” Angiogenesis, vol. 15, pp. 727–744, 2012. View at Publisher · View at Google Scholar
  29. C. Weber and H. Noels, “Atherosclerosis: current pathogenesis and therapeutic options,” Nature Medicine, vol. 17, no. 11, pp. 1410–1422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Capiralla, V. Vingtdeux, H. Zhao et al., “Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade,” Journal of Neurochemistry, vol. 120, no. 3, pp. 461–472, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. C.-C. Chan, L.-Y. Cheng, C.-L. Lin, Y.-H. Huang, H.-C. Lin, and F.-Y. Lee, “The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury,” Molecular Nutrition and Food Research, vol. 55, no. 12, pp. 1841–1849, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Kaneko, T. Anzai, M. Morisawa et al., “Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization,” Atherosclerosis, vol. 217, no. 2, pp. 350–357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Pallares, D. Calay, L. Cedo et al., “Enhanced anti-inflammatory effect of resveratrol and EPA in treated endotoxin-activated RAW 264.7 macrophages,” The British Journal of Nutrition, vol. 108, pp. 1562–1573, 2012. View at Publisher · View at Google Scholar
  34. D. Palmieri, B. Pane, C. Barisione et al., “Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development,” The Journal of Surgical Research, vol. 171, no. 2, pp. e237–e246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. C. O. Yi, B. T. Jeon, H. J. Shin et al., “Resveratrol activates AMPK and suppresses LPS-induced NF-kappaB-dependent COX-2 activation in RAW 264.7 macrophage cells,” Anatomy & Cell Biology, vol. 44, pp. 194–203, 2011. View at Google Scholar
  36. Y. Zong, L. Sun, B. Liu et al., “Resveratrol inhibits LPS-induced MAPKs activation via activation of the phosphatidylinositol 3-kinase pathway in murine RAW 264.7 macrophage cells,” PloS ONE, vol. 7, Article ID e44107, 2012. View at Google Scholar
  37. A. A. Qureshi, X. Q. Guan, J. C. Reis et al., “Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor,” Lipids in Health and Disease, vol. 11, article 76, 2012. View at Google Scholar
  38. M. S. Hayden and S. Ghosh, “NF-κB in immunobiology,” Cell Research, vol. 21, no. 2, pp. 223–244, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. I. L. M. H. Aye, B. J. Waddell, P. J. Mark, and J. A. Keelan, “Oxysterols inhibit differentiation and fusion of term primary trophoblasts by activating liver X receptors,” Placenta, vol. 32, no. 2, pp. 183–191, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Palozza, R. Simone, A. Catalano et al., “Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages,” The Journal of Nutritional Biochemistry, vol. 21, no. 1, pp. 34–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Palozza, R. Simone, A. Catalano et al., “Lycopene prevention of oxysterol-induced proinflammatory cytokine cascade in human macrophages: inhibition of NF-κB nuclear binding and increase in PPARγ expression,” The Journal of Nutritional Biochemistry, vol. 22, no. 3, pp. 259–268, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. L.-M. Zhong, Y. Zong, L. Sun et al., “Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells,” PLoS ONE, vol. 7, no. 2, Article ID e32195, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Tome-Carneiro, M. Gonzalvez, M. Larrosa et al., “Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective,” Annals of the New York Academy of Sciences, vol. 1290, pp. 37–51, 2013. View at Publisher · View at Google Scholar
  44. M. H. Kim, Y. J. Son, S. Y. Lee et al., “JAK2-targeted anti-inflammatory effect of a resveratrol derivative 2, 4-dihydroxy-N-(4-hydroxyphenyl)benzamide,” Biochemical Pharmacology, vol. 86, pp. 1747–1761, 2013. View at Publisher · View at Google Scholar